Evidence map›Paper›PMID 38804296›Full record

ReviewBiotech (Basel (Switzerland))2024

Challenges for the Post-Market Environmental Monitoring in the European Union Imposed by Novel Applications of Genetically Modified and Genome-Edited Organisms.

Marion Dolezel, Andreas Lang, Anita Greiter, Marianne Miklau, Michael Eckerstorfer, Andreas Heissenberger, Eva Willée, Wiebke Züghart

Abstract readReview
In one paragraph

Review in Biotech (Basel (Switzerland)), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Marion DolezelLand Use & Biosafety Unit, Umweltbundesamt-Environment Agency Austria (EAA), Spittelauer Laende 5, 1090 Vienna, Austria.ORCID 0000-0003-0037-6203
Andreas LangBüro Lang, Hoernlehof, Gresgen 108, 79669 Zell im Wiesental, Germany.
Anita GreiterLand Use & Biosafety Unit, Umweltbundesamt-Environment Agency Austria (EAA), Spittelauer Laende 5, 1090 Vienna, Austria.
Marianne MiklauLand Use & Biosafety Unit, Umweltbundesamt-Environment Agency Austria (EAA), Spittelauer Laende 5, 1090 Vienna, Austria.
Michael EckerstorferLand Use & Biosafety Unit, Umweltbundesamt-Environment Agency Austria (EAA), Spittelauer Laende 5, 1090 Vienna, Austria.ORCID 0000-0002-6827-904X
Andreas HeissenbergerLand Use & Biosafety Unit, Umweltbundesamt-Environment Agency Austria (EAA), Spittelauer Laende 5, 1090 Vienna, Austria.
Eva WilléeDivision of Terrestrial Monitoring, Federal Agency for Nature Conservation (BfN), Konstantinstr. 110, 53179 Bonn, Germany.
Wiebke ZüghartDivision of Terrestrial Monitoring, Federal Agency for Nature Conservation (BfN), Konstantinstr. 110, 53179 Bonn, Germany.

Funding

Federal Agency for Nature Conservation 3520 84 0300
6 · The paper itself

Abstract

Information on the state of the environment is important to achieve the objectives of the European Green Deal, including the EU's Biodiversity Strategy for 2030. The existing regulatory provisions for genetically modified organisms (GMOs) foresee an obligatory post-market environmental monitoring (PMEM) of potential adverse effects upon release into the environment. So far, GMO monitoring activities have focused on genetically modified crops. With the advent of new genomic techniques (NGT), novel GMO applications are being developed and may be released into a range of different, non-agricultural environments with potential implications for ecosystems and biodiversity. This challenges the current monitoring concepts and requires adaptation of existing monitoring programs to meet monitoring requirements. While the incorporation of existing biodiversity monitoring programs into GMO monitoring at the national level is important, additional monitoring activities will also be required. Using case examples, we highlight that monitoring requirements for novel GMO applications differ from those of GM crop plants previously authorized for commercial use in the European Union.

Indexed as

European Uniongenetic modificationgenome editingnew genomic techniquespost-market environmental monitoring

Identifiers

PMID38804296
PMCPMC11130885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.